RE:Based on current results…..Keytruda got approval with 19% CR at 12 months and more treatments and side effects. Vicinium is waiting on FDA decision early August and has a 17% CR at 12 months after 36 instillations. Anything above 20% would get us approved after complete trial of 100 patients and we would be another very decent option IMO. Accelerated Approval would probably come if we hit 67% or better IMO and that may take another 15-20 optimally treated patients . At 67% or better CR we would be a blockbuster drug treatment and capture a major share of the market. All IMHO. Time will tell. In a few weeks we may have data on another 3 patients and get a better picture. I hope they treat another 5 or more very soon.